Starting Wednesday, anybody aged 65 years old or over who tests positive using a COVID-19 rapid test will be eligible for the oral antiviral drug Paxlovid if their result is confirmed by a doctor, according to the Central Epidemic Command Center (CECC).
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan headline news
11/25/2024 10:49 AM - Business
U.S. dollar down in Taipei trading
11/25/2024 10:22 AM - Business
Taiwan shares open higher
11/25/2024 09:20 AM - Sports
President, VP celebrate historic victory by Taiwan’s 'baseball heroes'
11/25/2024 12:03 AM - Society
Thousands call for stricter rules on medical practitioners trained abroad
11/24/2024 10:20 PM